Zivo Bioscience (OTC:ZIVO) Stock, Quote.Headers.trade-ideas

Zivo Bioscience

Zivo Bioscience Inc is a research and development company operating in both the biotech and agtech sectors, with an intellectual property portfolio comprised of proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. The company's candidates are; Bovine Mastitis, Canine Joint Health, Human Immune Modulation, Companion Animal Food Ingredient, NDI (New Dietary Ingredient, and Skin Health.

Long Ideas

News

Penny Stocks

Small Cap

Insider Trades

Pre-Market Outlook

Markets

Trading Ideas

OCFC

SFBC

ZIVO

Although U.S. stocks closed higher on Monday, there were a few notable insider trades.

$2.8M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying

Intraday Update

Movers

ACCD

AULT

BENF

BROG

BTTR

BTWN

CMBM

CNTB

EURN

FSLY

GROM

IPDN

ISPO

LGVN

MKUL

MNTS

MSGM

MXCT

NBTX

NKGN

OGEN

OKYO

Grupo Aeroportuario del Centro NorteB de CV

OMAB

ORTX

RIVN

SGML

SNES

VEON

VINO

VSME

WHLR

XRTX

Gainers


	Orchard Therapeutics plc  (NASDAQ: ORTX) shares climbed 97.7% to $15.98 after the company agreed to be acquired by Japan&#39;s Kyowa Kirin for $16.00 per ADS in cash plus an additional contingent value right of $1.00 per ADS.


Why Accolade Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday&#39;s Mid-Day Session

APPH

BRCC

SMFL

The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies.

Top 5 Defensive Stocks Which Could Rescue Your Portfolio For July

ZIVO BIOSCIENCE INC by Zivo Bioscience, Inc.

Zivo Bioscience Inc

Zivo Bioscience Inc Warrants (29/04/2026)

<p>HEI intends to use the net proceeds from the offering to fund its contribution to the expected Maui wildfire tort litigation settlement and for general corporate purposes.</p>


Offerings

Hawaiian Electric Industries Intends To Make Offering Of $500M Of Shares Of Its Common Stock

SSIC

Silver Spike Investment Says Stockholders Have Voted At Special Meeting Of Stockholders To Approve Proposal Related To Acquisition Of CALP Loan Portfolio

<p>N-Sorb leverages company&#39;s proven 3-Phase Activ-Polymer&nbsp;platform technology to address recent concerns related to N-nitrosamine impurities in pharmaceuticals.</p>


AptarGroup Says N-Sorb Nitrosamine Mitigation Solution Has Been Accepted Into FDA Emerging Technology Program

<p>Ratings for Grocery Outlet Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GO#NASDAQ">GO</a>) were provided by 7 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.</p>
<p>The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $23.43, with a high estimate of $31.00 and a low estimate of $17.00. Highlighting a 18.08% decrease, the current average has fallen from the previous average price target of $28.60. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1727125287_0.png" alt="price target chart" /></p>
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
<p>The standing of Grocery Outlet Holding among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Karen Short</td>
<td>Melius Research</td>
<td>Announces</td>
<td>Hold</td>
<td>$17.00</td>
<td>-</td>
</tr>
<tr>
<td>Bill Kirk</td>
<td>Roth MKM</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$20.00</td>
<td>$22.00</td>
</tr>
<tr>
<td>Michael Lasser</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$21.00</td>
<td>$27.00</td>
</tr>
<tr>
<td>Joseph Feldman</td>
<td>Telsey Advisory Group</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$27.00</td>
<td>$31.00</td>
</tr>
<tr>
<td>Jeremy Hamblin</td>
<td>Craig-Hallum</td>
<td>Lowers</td>
<td>Hold</td>
<td>$20.00</td>
<td>$32.00</td>
</tr>
<tr>
<td>Joseph Feldman</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$31.00</td>
<td>$31.00</td>
</tr>
<tr>
<td>Anthony Bonadio</td>
<td>Wells Fargo</td>
<td>Announces</td>
<td>Overweight</td>
<td>$28.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Grocery Outlet Holding. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Grocery Outlet Holding compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts gauge the dynamics of price targets, providing estimates for the future value of Grocery Outlet Holding's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>For valuable insights into Grocery Outlet Holding's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/GO/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Grocery Outlet Holding analyst ratings.</strong></a></p>
<p>If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.</p>
<h2>About Grocery Outlet Holding</h2>
<p>Grocery Outlet Holding Corp is a grocery store operator in the United States. Its flexible buying model allows them to offer quality, name-brand opportunistic products at prices generally 40% to 70% below those of conventional retailers. The stores are run by Entrepreneurial independent operators which create a neighborhood feel through personalized customer service and a localized product offering.</p>
<h3>Financial Insights: Grocery Outlet Holding</h3>
<p><strong>Market Capitalization Analysis:</strong> Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.</p>
<p><strong>Positive Revenue Trend:</strong> Examining Grocery Outlet Holding's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of <strong>11.71%</strong> as of 30 June, 2024, showcasing a substantial increase in top-line earnings. When compared to others in the Consumer Staples sector, the company excelled with a growth rate higher than the average among peers.</p>
<p><strong>Net Margin:</strong> Grocery Outlet Holding's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>1.24%</strong> net margin, the company effectively manages costs and achieves strong profitability.</p>
<p><strong>Return on Equity (ROE):</strong> Grocery Outlet Holding's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of <strong>1.15%,</strong> the company showcases efficient use of equity capital and strong financial health.</p>
<p><strong>Return on Assets (ROA):</strong> The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of <strong>0.46%,</strong> the company showcases effective utilization of assets.</p>
<p><strong>Debt Management:</strong> Grocery Outlet Holding's debt-to-equity ratio is below the industry average at <strong>1.25</strong>, reflecting a lower dependency on debt financing and a more conservative financial approach.</p>
<h2>The Basics of Analyst Ratings</h2>
<p>Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.</p>
<p>Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Analyst Ratings

7 Analysts Assess Grocery Outlet Holding: What You Need To Know

<p>13 analysts have expressed a variety of opinions on Microchip Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCHP#NASDAQ">MCHP</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.</p>
<p>The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">6</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">6</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $96.92, a high estimate of $115.00, and a low estimate of $80.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 5.33%. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1727125260_0.png" alt="price target chart" /></p>
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
<p>A comprehensive examination of how financial experts perceive Microchip Technology is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>William Stein</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Hold</td>
<td>$80.00</td>
<td>$89.00</td>
</tr>
<tr>
<td>Harsh Kumar</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$100.00</td>
<td>$90.00</td>
</tr>
<tr>
<td>Quinn Bolton</td>
<td>Needham</td>
<td>Lowers</td>
<td>Buy</td>
<td>$96.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Hans Mosesmann</td>
<td>Rosenblatt</td>
<td>Lowers</td>
<td>Buy</td>
<td>$90.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Christopher Danely</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$92.00</td>
<td>$104.00</td>
</tr>
<tr>
<td>Craig Ellis</td>
<td>B. Riley Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$103.00</td>
<td>$110.00</td>
</tr>
<tr>
<td>William Stein</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$89.00</td>
<td>$96.00</td>
</tr>
<tr>
<td>Harlan Sur</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$100.00</td>
<td>$110.00</td>
</tr>
<tr>
<td>Christopher Rolland</td>
<td>Susquehanna</td>
<td>Lowers</td>
<td>Positive</td>
<td>$105.00</td>
<td>$115.00</td>
</tr>
<tr>
<td>Vivek Arya</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$90.00</td>
<td>$110.00</td>
</tr>
<tr>
<td>Hans Mosesmann</td>
<td>Rosenblatt</td>
<td>Maintains</td>
<td>Buy</td>
<td>$100.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Christopher Rolland</td>
<td>Susquehanna</td>
<td>Raises</td>
<td>Positive</td>
<td>$115.00</td>
<td>$105.00</td>
</tr>
<tr>
<td>Joseph Moore</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$100.00</td>
<td>$102.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Microchip Technology. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Microchip Technology compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts explore the dynamics of price targets, providing estimates for the future value of Microchip Technology's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
<p>Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Microchip Technology's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/MCHP/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Microchip Technology analyst ratings.</strong></a></p>
<h2>About Microchip Technology</h2>
<p>Microchip Technology became an independent company in 1989 when it was spun off from General Instrument. More than half of revenue comes from MCUs, which are used in a wide array of electronic devices from remote controls to garage door openers to power windows in autos. The company's strength lies in lower-end 8-bit MCUs that are suitable for a wider range of less technologically advanced devices, but the firm has expanded its presence in higher-end MCUs and analog chips as well.</p>
<h3>Microchip Technology: Delving into Financials</h3>
<p><strong>Market Capitalization:</strong> With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.</p>
<p><strong>Negative Revenue Trend:</strong> Examining Microchip Technology's financials over 3 months reveals challenges. As of 30 June, 2024, the company experienced a decline of approximately <strong>-45.76%</strong> in revenue growth, reflecting a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Information Technology sector.</p>
<p><strong>Net Margin:</strong> Microchip Technology's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of <strong>10.42%,</strong> the company may face hurdles in effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Microchip Technology's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of <strong>1.98%,</strong> the company may face hurdles in achieving optimal financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> Microchip Technology's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of <strong>0.82%,</strong> the company may face hurdles in achieving optimal financial performance.</p>
<p><strong>Debt Management:</strong> Microchip Technology's debt-to-equity ratio is notably higher than the industry average. With a ratio of <b>0.97</b>, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.</p>
<h2>What Are Analyst Ratings?</h2>
<p>Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.</p>
<p>In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


MCHP

13 Analysts Assess Microchip Technology: What You Need To Know

<p>Throughout the last three months, 4 analysts have evaluated Jefferies Financial Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JEF#NYSE">JEF</a>), offering a diverse set of opinions from bullish to bearish.</p>
<p>The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $64.0, with a high estimate of $67.00 and a low estimate of $59.00. This upward trend is apparent, with the current average reflecting a 14.96% increase from the previous average price target of $55.67.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1727125251_0.png" alt="price target chart" /></p>
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
<p>The analysis of recent analyst actions sheds light on the perception of Jefferies Financial Gr by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Ryan Kenny</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$64.00</td>
<td>$59.00</td>
</tr>
<tr>
<td>Brennan Hawken</td>
<td>UBS</td>
<td>Announces</td>
<td>Buy</td>
<td>$67.00</td>
<td>-</td>
</tr>
<tr>
<td>Chris Kotowski</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$66.00</td>
<td>$64.00</td>
</tr>
<tr>
<td>Ryan Kenny</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$59.00</td>
<td>$44.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Jefferies Financial Gr. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Jefferies Financial Gr compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts provide insights into price targets, offering estimates for the future value of Jefferies Financial Gr's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>To gain a panoramic view of Jefferies Financial Gr's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/JEF/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Jefferies Financial Gr analyst ratings.</strong></a></p>
<h2>Discovering Jefferies Financial Gr: A Closer Look</h2>
<p>Jefferies Financial Group Inc is a diversified financial services company. It has two reportable segments; Investment Banking and Capital Markets which is also the majority revenue generating segment, includes securities, commodities, corporate lending, futures and foreign exchange capital markets activities and its investment banking business, which provides underwriting and financial advisory services to clients across different sectors. The Asset Management reportable business segment provides alternative investment management services to investors in the U.S. and overseas and generates investment income from capital invested in and managed by it or its affiliated asset managers.</p>
<h3>Financial Milestones: Jefferies Financial Gr's Journey</h3>
<p><strong>Market Capitalization Analysis:</strong> The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.</p>
<p><strong>Positive Revenue Trend:</strong> Examining Jefferies Financial Gr's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of <strong>52.39%</strong> as of 31 May, 2024, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Financials sector.</p>
<p><strong>Net Margin:</strong> The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of <strong>5.75%,</strong> the company may need to address challenges in effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> Jefferies Financial Gr's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of <strong>1.47%,</strong> the company may encounter challenges in delivering satisfactory returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> Jefferies Financial Gr's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of <strong>0.23%,</strong> the company may face hurdles in achieving optimal financial performance.</p>
<p><strong>Debt Management:</strong> Jefferies Financial Gr's debt-to-equity ratio is below the industry average at <strong>2.04</strong>, reflecting a lower dependency on debt financing and a more conservative financial approach.</p>
<h2>Understanding the Relevance of Analyst Ratings</h2>
<p>Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.</p>
<p>Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.</p>
<p>If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Navigating 4 Analyst Ratings For Jefferies Financial Gr

<p>RBC Bearings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBC#NYSE">RBC</a>) has outperformed the market over the past 15 years by 6.54% on an annualized basis producing an average annual return of 18.4%. Currently, RBC Bearings has a market capitalization of $8.67 billion. </p>
<p><strong>Buying $1000 In RBC:</strong> If an investor had bought $1000 of RBC stock 15 years ago, it would be worth <strong>$12,698.64</strong> today based on a price of $297.91 for RBC at the time of writing.</p>
<h3>RBC Bearings's Performance Over Last 15 Years</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1727125215_0.png" alt="comp_fig" /></p>
<p>Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.</p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Here's How Much You Would Have Made Owning RBC Bearings Stock In The Last 15 Years

<p>Icon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICLR#NASDAQ">ICLR</a>) has outperformed the market over the past 10 years by 6.67% on an annualized basis producing an average annual return of 17.87%. Currently, Icon has a market capitalization of $24.54 billion. </p>
<p><strong>Buying $100 In ICLR:</strong> If an investor had bought $100 of ICLR stock 10 years ago, it would be worth <strong>$515.21</strong> today based on a price of $296.30 for ICLR at the time of writing.</p>
<h3>Icon's Performance Over Last 10 Years</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1727125210_0.png" alt="comp_fig" /></p>
<p>Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.</p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


ICLR

Here's How Much $100 Invested In Icon 10 Years Ago Would Be Worth Today

<p>During the last three months, 24 analysts shared their evaluations of Uber Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>), revealing diverse outlooks from bullish to bearish.</p>
<p>Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">11</td>
<td style="text-align: right;">12</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">7</td>
<td style="text-align: right;">6</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $88.42, along with a high estimate of $98.00 and a low estimate of $75.00. Marking an increase of 1.85%, the current average surpasses the previous average price target of $86.81. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1727125208_0.png" alt="price target chart" /></p>
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
<p>The perception of Uber Technologies by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Deepak Mathivanan</td>
<td>Cantor Fitzgerald</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$90.00</td>
<td>$90.00</td>
</tr>
<tr>
<td>Ken Gawrelski</td>
<td>Wells Fargo</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$97.00</td>
<td>$97.00</td>
</tr>
<tr>
<td>Youssef Squali</td>
<td>Truist Securities</td>
<td>Maintains</td>
<td>Buy</td>
<td>$88.00</td>
<td>$88.00</td>
</tr>
<tr>
<td>Deepak Mathivanan</td>
<td>Cantor Fitzgerald</td>
<td>Announces</td>
<td>Overweight</td>
<td>$90.00</td>
<td>-</td>
</tr>
<tr>
<td>Rob Sanderson</td>
<td>Loop Capital</td>
<td>Raises</td>
<td>Buy</td>
<td>$84.00</td>
<td>$83.00</td>
</tr>
<tr>
<td>Justin Post</td>
<td>B of A Securities</td>
<td>Maintains</td>
<td>Buy</td>
<td>$88.00</td>
<td>$88.00</td>
</tr>
<tr>
<td>Ronald Josey</td>
<td>JMP Securities</td>
<td>Raises</td>
<td>Market Outperform</td>
<td>$80.00</td>
<td>$75.00</td>
</tr>
<tr>
<td>Ronald Josey</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$98.00</td>
<td>$96.00</td>
</tr>
<tr>
<td>Brad Erickson</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$80.00</td>
<td>$80.00</td>
</tr>
<tr>
<td>Rohit Kulkarni</td>
<td>Roth MKM</td>
<td>Raises</td>
<td>Buy</td>
<td>$90.00</td>
<td>$89.00</td>
</tr>
<tr>
<td>Eric Sheridan</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Buy</td>
<td>$90.00</td>
<td>$85.00</td>
</tr>
<tr>
<td>Ken Gawrelski</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$97.00</td>
<td>$91.00</td>
</tr>
<tr>
<td>Mark Mahaney</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>Outperform</td>
<td>$90.00</td>
<td>$80.00</td>
</tr>
<tr>
<td>Youssef Squali</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$88.00</td>
<td>$86.00</td>
</tr>
<tr>
<td>Tom White</td>
<td>DA Davidson</td>
<td>Raises</td>
<td>Buy</td>
<td>$82.00</td>
<td>$81.00</td>
</tr>
<tr>
<td>Bernie McTernan</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$90.00</td>
<td>$90.00</td>
</tr>
<tr>
<td>Ronald Josey</td>
<td>JMP Securities</td>
<td>Maintains</td>
<td>Market Outperform</td>
<td>$75.00</td>
<td>$75.00</td>
</tr>
<tr>
<td>Brian Pitz</td>
<td>BMO Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$92.00</td>
<td>$92.00</td>
</tr>
<tr>
<td>Brian Nowak</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$95.00</td>
<td>$90.00</td>
</tr>
<tr>
<td>John Blackledge</td>
<td>TD Cowen</td>
<td>Raises</td>
<td>Buy</td>
<td>$90.00</td>
<td>$88.00</td>
</tr>
<tr>
<td>Conor Cunningham</td>
<td>Melius Research</td>
<td>Announces</td>
<td>Hold</td>
<td>$77.00</td>
<td>-</td>
</tr>
<tr>
<td>Shweta Khajuria</td>
<td>Wolfe Research</td>
<td>Announces</td>
<td>Outperform</td>
<td>$90.00</td>
<td>-</td>
</tr>
<tr>
<td>Bernie McTernan</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$90.00</td>
<td>$90.00</td>
</tr>
<tr>
<td>Ken Gawrelski</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$91.00</td>
<td>$89.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Uber Technologies. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Uber Technologies compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts navigate through adjustments in price targets, providing estimates for Uber Technologies's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
<p>For valuable insights into Uber Technologies's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/UBER/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Uber Technologies analyst ratings.</strong></a></p>
<h2>Get to Know Uber Technologies Better</h2>
<p>Uber Technologies is a technology provider that matches riders with drivers, hungry people with restaurants and food delivery service providers, and shippers with carriers. The firm's on-demand technology platform could eventually be used for additional products and services, such as autonomous vehicles, delivery via drones, and Uber Elevate, which, as the firm refers to it, provides "aerial ride-sharing." Uber Technologies is headquartered in San Francisco and operates in over 63 countries with over 150 million users who order rides or food at least once a month.</p>
<h3>Uber Technologies: Delving into Financials</h3>
<p><strong>Market Capitalization:</strong> Positioned above industry average, the company's market capitalization underscores its superiority in size, indicative of a strong market presence.</p>
<p><strong>Revenue Growth:</strong> Over the 3 months period, Uber Technologies showcased positive performance, achieving a revenue growth rate of <strong>15.93%</strong> as of 30 June, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Industrials sector.</p>
<p><strong>Net Margin:</strong> The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of <strong>9.49%,</strong> the company showcases strong profitability and effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of <strong>8.67%,</strong> the company showcases effective utilization of equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Uber Technologies's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>2.5%</strong> ROA, the company effectively utilizes its assets for optimal returns.</p>
<p><strong>Debt Management:</strong> Uber Technologies's debt-to-equity ratio is below the industry average. With a ratio of <b>0.9</b>, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.</p>
<h2>The Basics of Analyst Ratings</h2>
<p>Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.</p>
<p>In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


UBER

Navigating 24 Analyst Ratings For Uber Technologies

<p><strong>GameStop Corp</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GME#NYSE">GME</a>) shares are rising in extended trading Monday after the company announced the completion of its <a href="https://www.benzinga.com/pressreleases/24/09/g40990738/gamestop-completes-at-the-market-equity-offering-program">at-the-market offering program</a>.</p>
<p><strong>What Happened:</strong> After the market close on Monday, GameStop said it completed its <a href="https://www.benzinga.com/news/earnings/24/09/40803991/gamestop-q2-earnings-highlights-revenue-miss-eps-beat-cash-update-and-more">previously announced</a> offering program. </p>
<p>On Sept. 10, GameStop updated its prospectus to allow the company to offer and sell up to 20 million shares of its common stock from time to time.  </p>
<p>The video game retailer announced Monday it sold the maximum number of shares registered under the program for gross proceeds of approximately $400 million. GameStop expects to use net proceeds for general corporate purposes, which may include acquisitions and investments.</p>
<p>GameStop stock is extremely popular among retail investors, which has helped spark some wild swings in the stock in recent years. GameStop management has taken advantage of the volatility by raising cash several times along the way. </p>
<p>GameStop had $4.204 billion in cash, cash equivalents and marketable securities as of the end of the second quarter. </p>
<p><strong>Don&#8217;t Miss: <a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40971260/trumps-historic-bitcoin-transaction-ethereum-co-founder-backs-trump-over-harris-for-crypto">Trump&#8217;s Historic Bitcoin Transaction, Ethereum Co-Founder Backs Trump Over Harris For Crypto, Gamestop Customer&#8217;s Bitcoin Windfall, And More: This Week In Cryptocurrency</a></strong></p>
<p><strong>GME Price Action: </strong>GameStop shares were up 1.34% in after-hours, trading at $22.31 at the time of publication Monday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.</p>
<p><em>Photo: <a href="https://www.flickr.com/photos/jjbers/">JJBers</a> from Flickr.</em></p>


GameStop Stock Jumps Monday After The Bell: What's Going On?

EARN

Ellington Credit Postpones Its 2024 Annual Meeting Of Shareholders, Originally Scheduled For September 26, 2024

<p><strong>Snowflake Inc.</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNOW#NYSE">SNOW</a>) shares are trading lower in Monday's after-hours session after the company announced a $2 billion private placement of <a href="https://www.benzinga.com/pressreleases/24/09/b40990749/snowflake-announces-proposed-private-placement-of-2-0-billion-of-convertible-senior-notes">senior convertible notes.</a></p>
<p><strong>The Details:</strong> Snowflake announced it intends to offer $1 billion aggregate principal amount of its convertible senior notes due 2027 and a $1 billion aggregate principal amount of its convertible senior notes due 2029.</p>
<p>The company also intends to grant the initial purchasers of the notes options to purchase up to an additional $150 million aggregate principal amount of the 2027 notes and up to an additional $150 million aggregate principal amount of the 2029 notes.&nbsp;</p>
<p><strong>Read Next: </strong><a href="https://www.benzinga.com/news/earnings/24/09/40948948/homebuilder-lennar-reports-better-than-expected-q3-results-details"><strong>Homebuilder Lennar Reports Better-Than-Expected Q3 Results: Details</strong></a></p>
<p>According to data from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Snowflake shares are trading below the stock&#8217;s 50-day moving average of $121.30 and near its 52-week low of $107.13.&nbsp;</p>
<h1 class="wp-block-heading"><strong>Will SNOW Stock Go Up?</strong></h1>
<p>When trying to assess whether or not Snowflake will trade higher from current levels, it's a good idea to take a look at analyst forecasts. </p>
<p>Wall Street analysts have an average 12-month price target of $166.93 on Snowflake. The Street high target is currently at $220 and the Street low target is $121. Of all the analysts covering Snowflake, 19 have positive ratings, nine have neutral ratings and no one has negative ratings.</p>
<p>In the last month, no analysts have adjusted price targets. Here's a look at recent price target changes <a href="https://www.benzinga.com/quote/SNOW/analyst-ratings">[Analyst Ratings]</a>. Benzinga also tracks Wall Street's most accurate analysts. Check out how analysts covering Snowflake have performed in recent history. </p>
<p>Stocks don't move in a straight line. The average stock market return is approximately 10% per year. Snowflake is 40.11% down year-to-date. The average analyst price target suggests the stock could have further upside ahead.</p>
<p>For a broad overview of everything you need to know about Snowflake, visit <a href="https://www.benzinga.com/quote/SNOW">here</a>. If you want to go above and beyond, there's no better tool to help you do just that than <a href="https://pro.benzinga.com/">Benzinga Pro</a>. Start your free trial today.</p>
<p><strong>SNOW Price Action:</strong> According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Snowflake shares are down 2.62% after-hours at $110.29 at the time of publication Monday.</p>
<p><strong>Read Also:</strong></p>
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/09/40957779/shipping-giants-fedex-ups-stocks-slip-friday-whats-going-on"><strong>Shipping Giants FedEx, UPS Stocks Slip Friday: What&#8217;s Going On?</strong></a></li>
</ul>
<p><em>Image: Shutterstock&nbsp;</em></p>


After-Hours Center

SNOW

Snowflake Stock Dips On Offering After-Hours: What To Know

<p>The Notes were priced at&nbsp;98.855%&nbsp;of the principal amount and will mature on February 1, 2035. The offering is expected to close on September 26, 2024, subject to the satisfaction of customary closing conditions. The Notes will be fully and unconditionally guaranteed, jointly and severally, by the Company, Invitation Homes OP GP LLC, and IH Merger Sub, LLC.</p>


INVH

Invitation Homes Prices Public Offering Of $500M Of 4.875% Senior Notes Due 2035

<p>Financial giants have made a conspicuous bullish move on Vistra. Our analysis of options history for Vistra (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VST#NYSE">VST</a>) revealed 96 unusual trades.</p>
<p>Delving into the details, we found 41% of traders were bullish, while 40% showed bearish tendencies. Out of all the trades we spotted, 12 were puts, with a value of $643,223, and 84 were calls, valued at $7,549,105.</p>
<h3>Expected Price Movements</h3>
<p>Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $50.0 to $155.0 for Vistra during the past quarter. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.</p>
<p>This data can help you track the liquidity and interest for Vistra's options for a given strike price.</p>
<p>Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Vistra's whale activity within a strike price range from $50.0 to $155.0 in the last 30 days. </p>
<h3>Vistra Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1727124345_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th style="text-align: right;"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>VST</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$24.4</td>
<td>$23.9</td>
<td>$24.2</td>
<td>$90.00</td>
<td>$605.0K</td>
<td>802</td>
<td style="text-align: right;">253</td>
</tr>
<tr>
<td>VST</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$34.5</td>
<td>$34.2</td>
<td>$34.5</td>
<td>$115.00</td>
<td>$345.0K</td>
<td>0</td>
<td style="text-align: right;">100</td>
</tr>
<tr>
<td>VST</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>10/18/24</td>
<td>$21.6</td>
<td>$21.3</td>
<td>$21.3</td>
<td>$87.50</td>
<td>$223.6K</td>
<td>708</td>
<td style="text-align: right;">121</td>
</tr>
<tr>
<td>VST</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$10.2</td>
<td>$10.1</td>
<td>$10.1</td>
<td>$120.00</td>
<td>$135.3K</td>
<td>3.1K</td>
<td style="text-align: right;">193</td>
</tr>
<tr>
<td>VST</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$6.7</td>
<td>$6.4</td>
<td>$6.4</td>
<td>$85.00</td>
<td>$112.6K</td>
<td>162</td>
<td style="text-align: right;">176</td>
</tr>
</tbody>
</table>
</p>
<h3>About Vistra</h3>
<p>Vistra Energy is one of the largest power producers and retail energy providers in the us Following the 2024 Energy Harbor acquisition, Vistra owns 41 gigawatts of nuclear, coal, natural gas, and solar power generation along with one of the largest utility-scale battery projects in the world. Its retail electricity business serves 5 million customers in 20 states, including almost a third of all Texas electricity consumers. Vistra emerged from the Energy Future Holdings bankruptcy as a stand-alone entity in 2016. It acquired Dynegy in 2018.</p>
<p>Having examined the options trading patterns of Vistra, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance</p>
<h3>Current Position of Vistra</h3>
<ul>
<li>Currently trading with a volume of 15,603,256, the VST's price is up by 3.85%, now at $112.03. </li>
<li>RSI readings suggest the stock is currently may be overbought.</li>
<li>Anticipated earnings release is in 43 days.</li>
</ul>
<h3>What Analysts Are Saying About Vistra</h3>
<p>A total of 3 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $118.66666666666667.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; Maintaining their stance, an analyst from Morgan Stanley continues to hold a Overweight rating for Vistra, targeting a price of $132.<br />
&#x2A; An analyst from BMO Capital persists with their Outperform rating on Vistra, maintaining a target price of $125.<br />
&#x2A; In a cautious move, an analyst from Jefferies downgraded its rating to Buy, setting a price target of $99. </p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Vistra with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.</p>


Options

Market Whales and Their Recent Bets on VST Options

<p>Investors with a lot of money to spend have taken a bullish stance on <strong>ZIM Integrated Shipping</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZIM#NYSE">ZIM</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with ZIM, it often means somebody knows something is about to happen.</p>
<p>So how do we know what these investors just did? </p>
<p>Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 35 uncommon options trades for ZIM Integrated Shipping.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 48% bullish and 34%, bearish.</p>
<p>Out of all of the special options we uncovered, 16 are puts, for a total amount of $1,146,453, and 19 are calls, for a total amount of $1,120,580.</p>
<h3>What's The Price Target?</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $15.0 and $25.0 for ZIM Integrated Shipping, spanning the last three months.</p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for ZIM Integrated Shipping's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across ZIM Integrated Shipping's significant trades, within a strike price range of $15.0 to $25.0, over the past month.</p>
<h3>ZIM Integrated Shipping Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1727124340_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>ZIM</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$6.55</td>
<td>$6.3</td>
<td>$6.34</td>
<td>$25.00</td>
<td>$253.6K</td>
<td>1.8K</td>
<td>423</td>
</tr>
<tr>
<td>ZIM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>10/18/24</td>
<td>$7.15</td>
<td>$7.1</td>
<td>$7.1</td>
<td>$15.00</td>
<td>$142.0K</td>
<td>1.3K</td>
<td>683</td>
</tr>
<tr>
<td>ZIM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$3.3</td>
<td>$2.95</td>
<td>$2.95</td>
<td>$20.00</td>
<td>$118.0K</td>
<td>13.2K</td>
<td>514</td>
</tr>
<tr>
<td>ZIM</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>10/18/24</td>
<td>$7.15</td>
<td>$6.95</td>
<td>$7.05</td>
<td>$15.00</td>
<td>$105.7K</td>
<td>1.3K</td>
<td>233</td>
</tr>
<tr>
<td>ZIM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>10/18/24</td>
<td>$7.35</td>
<td>$6.95</td>
<td>$6.96</td>
<td>$15.00</td>
<td>$96.9K</td>
<td>1.3K</td>
<td>1.7K</td>
</tr>
</tbody>
</table>
</p>
<h3>About ZIM Integrated Shipping</h3>
<p>ZIM Integrated Shipping Services Ltd is an asset-light container liner shipping company. It offers tailored services, including land transportation and logistical services, specialized shipping solutions, including the transportation of out-of-gauge cargo, refrigerated cargo, and dangerous and hazardous cargo. Its services include Cargo Services, Digital Services, Schedules, and Shipping Trades and Lines. Geographically, it derives a majority of its revenue from the Pacific trade region.</p>
<p>Having examined the options trading patterns of ZIM Integrated Shipping, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance</p>
<h3>Present Market Standing of ZIM Integrated Shipping</h3>
<ul>
<li>Trading volume stands at 10,677,136, with ZIM's price up by 10.47%, positioned at $22.16.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 51 days.</li>
</ul>
<h3>What The Experts Say On ZIM Integrated Shipping</h3>
<p>In the last month, 2 experts released ratings on this stock with an average target price of $12.1.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; Consistent in their evaluation, an analyst from B of A Securities keeps a Underperform rating on ZIM Integrated Shipping with a target price of $13.<br />
&#x2A; Reflecting concerns, an analyst from JP Morgan lowers its rating to Underweight with a new price target of $10.</p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest ZIM Integrated Shipping options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>


Market Whales and Their Recent Bets on ZIM Options

<p>Investors with a lot of money to spend have taken a bearish stance on <strong>PENN Entertainment</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PENN#NASDAQ">PENN</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with PENN, it often means somebody knows something is about to happen.</p>
<p>So how do we know what these investors just did? </p>
<p>Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 8 uncommon options trades for PENN Entertainment.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 37% bullish and 50%, bearish.</p>
<p>Out of all of the special options we uncovered, 5 are puts, for a total amount of $414,027, and 3 are calls, for a total amount of $102,120.</p>
<h3>Expected Price Movements</h3>
<p>Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $17.5 to $25.0 for PENN Entertainment during the past quarter. </p>
<h3>Volume &amp; Open Interest Trends</h3>
<p>Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in PENN Entertainment's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to PENN Entertainment's substantial trades, within a strike price spectrum from $17.5 to $25.0 over the preceding 30 days.</p>
<h3>PENN Entertainment 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1727124334_0.png" alt="Options Call Chart" /></p>
<h3>Noteworthy Options Activity:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>PENN</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$3.1</td>
<td>$2.91</td>
<td>$3.05</td>
<td>$20.00</td>
<td>$272.9K</td>
<td>116</td>
<td>1.1K</td>
</tr>
<tr>
<td>PENN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/27/24</td>
<td>$0.37</td>
<td>$0.36</td>
<td>$0.36</td>
<td>$20.00</td>
<td>$46.6K</td>
<td>1.0K</td>
<td>2.7K</td>
</tr>
<tr>
<td>PENN</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/15/24</td>
<td>$0.88</td>
<td>$0.84</td>
<td>$0.88</td>
<td>$17.50</td>
<td>$44.4K</td>
<td>38</td>
<td>1.5K</td>
</tr>
<tr>
<td>PENN</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$2.98</td>
<td>$2.97</td>
<td>$2.98</td>
<td>$20.00</td>
<td>$41.4K</td>
<td>116</td>
<td>140</td>
</tr>
<tr>
<td>PENN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>10/18/24</td>
<td>$1.05</td>
<td>$0.99</td>
<td>$1.05</td>
<td>$20.00</td>
<td>$30.0K</td>
<td>10.6K</td>
<td>638</td>
</tr>
</tbody>
</table>
</p>
<h3>About PENN Entertainment</h3>
<p>Penn Entertainment's origins date back to its 1972 racetrack opening in Pennsylvania. Today, Penn operates 43 properties across 20 states and 12 brands, including Hollywood Casino and Ameristar. Land-based casinos represented 89% of total sales in 2023; 11% was from the interactive segment, which includes sports, iGaming, and media revenue. The retail portfolio generates mid-30s EBITDAR margins and helps position the company to obtain licenses for the digital wagering markets. Additionally, Penn's media assets, theScore and ESPN (starting with its partnership launch in November 2023), provide access to sports betting/iGaming technology and clientele, helping it form a leading digital position.</p>
<h3>Present Market Standing of PENN Entertainment</h3>
<ul>
<li>With a trading volume of 3,203,819, the price of PENN is down by -2.84%, reaching $19.51.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 38 days from now.</li>
</ul>
<h3>Expert Opinions on PENN Entertainment</h3>
<p>Over the past month, 1 industry analysts have shared their insights on this stock, proposing an average target price of $20.0.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Morgan Stanley has decided to maintain their Equal-Weight rating on PENN Entertainment, which currently sits at a price target of $20. </p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for PENN Entertainment, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.</p>


PENN

Looking At PENN Entertainment's Recent Unusual Options Activity

<p><a href="https://www.axios.com/2024/09/23/democrats-republicans-emergency-abortion-bill">https://www.axios.com/2024/09/23/democrats-republicans-emergency-abortion-bill</a></p>
<p>Top Senate Democrats will force Republicans to vote on access to emergency abortion care this week, in one of Senate Majority Leader Chuck Schumer (D-N.Y.)'s final pre-election messaging pushes, Axios has learned.</p>
<p><strong>The big picture:</strong> <a href="https://www.axios.com/2024/09/17/georgia-abortion-death-democrats">The death of a Georgia woman</a> who was refused emergency care because of the state's abortion restrictions has become the latest rallying cry for Democrats who are wagering abortion will be a winning issue for their party on Nov. 5.</p>
<ul>
<li>Sen. Patty Murray (D-Wash.), will seek unanimous consent Tuesday to pass a resolution she introduced last week affirming that every person has a right to emergency health care, including abortion care.</li>
<li>Murray's move will force Republicans to either block the measure or pass it.</li>
<li>Sen. Tammy Baldwin (D-Wisc.) also will seek unanimous consent Tuesday on a bill that would offset travels costs for people seeking abortion care.</li>
</ul>
<p><strong>Catch up quick: </strong>An investigation published by <a href="https://www.propublica.org/article/georgia-abortion-ban-amber-thurman-death">ProPublica</a> last week highlighted the circumstances of Amber Nicole Thurman's 2022 death — the first publicly reported death caused by delayed abortion care.</p>
<p><strong>Zoom in: </strong>The maneuvers represent Senate Democrats' parting shots in their messaging <a href="https://www.axios.com/2024/09/18/senate-republicans-border-laken-riley-bill-katie-britt">war with with Republicans</a> before lawmakers go home to campaign ahead of Election Day.</p>
<ul>
<li>Schumer will join a press conference at the Capitol Tuesday focused on access to emergency reproductive care.</li>
<li>Senate Democrats have made abortion access their most prominent campaign issue, forcing Republicans this month <a href="https://www.axios.com/2024/09/12/schumer-trump-ivf-vote-senate">to block a bill</a> promoting universal IVF coverage.</li>
</ul>
<p>&nbsp;</p>
<ul>
<li>Schumer has used the Senate floor to <a href="https://www.axios.com/2024/06/05/senate-gop-mcconnell-thune-political-vote-2024-election">go on offense</a> against Republicans over everything from reproductive rights to gun control in the run-up to the election.</li>
</ul>
<p><strong>Zoom out: </strong>Senate Republicans have blocked similar attempts from Democrats in the past few months, and there is little reason to believe the outcome will be different this time around.</p>
<ul>
<li>Abortion access will be a top issue in a number of states where Schumer is trying to protect incumbents so he can retain his majority.</li>
<li>There also will be abortion measures on the ballot in Arizona, Florida, Maryland, Montana and Nevada — all states where Schumer is trying either to flip or keep a seat.</li>
</ul>


Macro Economic Events

Politics

Economics

General

PGNY

'Senate Dems' Emergency Abortion Care Blitz; Top Senate Democrats Will Force Republicans To Vote On Access To Emergency Abortion Care This Week, In One Of Senate Majority Leader Chuck Schumer's Final Pre-Election Messaging Pushes' - Axios

<p><a href="https://www.bloomberg.com/news/articles/2024-09-23/novo-ceo-blames-ozempic-s-high-cost-on-drug-middlemen-s-tactics">https://www.bloomberg.com/news/articles/2024-09-23/novo-ceo-blames-ozempic-s-high-cost-on-drug-middlemen-s-tactics</a></p>
<p>&nbsp;</p>
<p>Novo Nordisk A/S Chief Executive Officer Lars Fruergaard Jorgensen will use a familiar argument to defend the US prices of blockbuster drugs Ozempic and Wegovy when he appears Tuesday before a congressional committee led by Senator Bernie Sanders: It's the middlemen.&nbsp;</p>


Biotech

'Novo CEO Blames Ozempic's High Cost on Drug Middlemen's Tactics' - Bloomberg News

<p><strong>Palantir Technologies Inc. </strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>) shares moved higher Monday. The stock joined the S&amp;P 500 as part of the index&#8217;s <a href="https://www.benzinga.com/etfs/broad-u-s-equity-etfs/24/09/40960886/palantir-dell-to-join-s-p-500-friday-heres-how-tesla-stock-has-performed-since-its-add">quarterly rebalancing.</a></p>
<p><strong>The Details:</strong> Palantir replaced <strong>American Airlines Group, Inc.</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AAL#NYSE">AAL</a>) in the<strong> S&amp;P 500 index </strong>which could boost the stock as it gains wider exposure to investors and as shares are accumulated to be included in index funds that mirror the S&amp;P 500. </p>
<p>Palantir shares climbed Monday despite a downgrade from Raymond James who lowered the stock's rating from Outperform to Market Perform. </p>
<p>The stock gained 20% over the past month on multiple catalysts, including several new contracts and its inclusion in the S&amp;P 500. </p>
<p>&nbsp;<strong>Read Next: </strong><a href="https://www.benzinga.com/news/earnings/24/09/40948948/homebuilder-lennar-reports-better-than-expected-q3-results-details"><strong>Homebuilder Lennar Reports Better-Than-Expected Q3 Results: Details</strong></a></p>
<p>Last week, the company announced a $99.8 million contract granted by the DEVCOM Army Research Laboratory (ARL) that broadens Maven Smart System access across military branches, including the Army, Air Force, Space Force, Navy and U.S. Marine Corps. </p>
<p>As part of the new contract, Palantir's platform will enhance AI-enabled battlespace awareness and support global integration, force management, logistics and joint targeting workflows to improve military interoperability and readiness.</p>
<p>"This contract vehicle will allow every military department to tap into the innovation that the Office of Secretary of Defense and NGA have created through Maven to accelerate their own CJADC2 programs," said <strong>Akash Jain</strong>, president of Palantir USG.</p>
<p><strong>PLTR Price Action: </strong>According to data from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Palantir shares are trading above the stock&#8217;s 50-day moving average of $30.50 and ended Monday's session at $37.95, just shy of the 52-week high of $38.19 also reached on Monday.</p>
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/09/40957779/shipping-giants-fedex-ups-stocks-slip-friday-whats-going-on"><strong>Shipping Giants FedEx, UPS Stocks Slip Friday: What&#8217;s Going On?</strong></a></li>
</ul>
<p><em>Photo: Shutterstock</em></p>


PLTR

What Happened With Palantir Stock Today?

<p><strong>Amkor Technology</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amkr#NASDAQ">AMKR</a>) shares have lost 17.7% in the past three months, underperforming the Zacks Electronics - Semiconductors industry and the S&amp;P 500 index&#39;s return of 2.2% and 4.2%, respectively. The underperformance is attributable to a myriad of challenges that are keeping the investors away.</p>
<p>Throughout the past year, Amkor struggled with supply chain disruption caused by geopolitical tension and faced macroeconomic challenges caused by high inflation and interest rates. The outsourced semiconductor packaging and test services (OSAT) leader also suffered from the shortage of semiconductors, keeping its top and bottom lines constrained.</p>
<p>In the previous quarter, AMKR reported that it was still suffering from the slow recovery of automotive and industrial space, along with softness in traditional data center client demand. AMKR&#39;s several factories have been reported not to be functioning at full capacity, hence hurting its top-line growth.</p>
<p>Amkor is also suffering from lower demand for its 2.5D integrated circuit caused by the inventory corrections in the automotive and industrial markets. In recent times, Amkor&#39;s operating expenses have also risen due to the construction of a new factory in Vietnam. This has affected its bottom line.</p>
<h3>Amkor Technology Three Month Performance</h3>
<p><img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/2f/78862.jpg?v=495650514" /></p>
<p>Image Source: Zacks Investment Research</p>
<h2>AMKR Faces Stiff Competition in the OSAT Market</h2>
<p>Amkor is a major player in the OSAT space, providing solutions for innovative packaging and test technologies with a solid reputation for high-volume manufacturing. AMKR&#39;s presence in multiple countries in Asia and Europe makes it a global player in the OSAT space. The company partnered with the world&#39;s leading tech giants, including Apple, Qualcomm, Intel, Broadcomm, AMD and many more.</p>
<p>In late 2023, Apple partnered with Amkor as the largest customer of the latter&#39;s manufacturing and packaging facility in Peoria. In this partnership, Amkor was contracted to provide chip packaging solutions to Apple. This partnership grew over their decade-long relationship.</p>
<p>However, Amkor faces stiff competition in the OSAT space from <strong>Taiwan Semiconductor Manufacturing Company</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tsm#NYSE">TSM</a>) and <strong>ASE Technology Holding </strong>(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/asx#NYSE">ASX</a>).</p>
<p>Both ASE Technology and Taiwan Semiconductor operate in the OSAT space internationally. TSM and ASX have their own fabrication facilities. Although TSM&#39;s primary focus is on chip manufacturing, it has a strong advanced packaging division. ASX, on the other hand, is focused on IC packaging, testing and assembly services with products like System-in-Package and 3D IC technologies.</p>
<p>With all these headwinds, AMKR expects third-quarter fiscal 2024 revenues in the range of $1.785-$1.885 billion (mid-point $1.835 billion), while the Zacks Consensus Estimate for the same is pegged at $1.84 billion. The Zacks Consensus Estimate for fiscal 2024 revenues is pegged at $6.51 billion, indicating an improvement of 0.15% year over year.</p>
<h2>Conclusion</h2>
<p>Amkor is facing macroeconomic challenges, higher operational costs, stiff competition and a slow growth rate due to sluggish recovery in its end markets. Currently, AMKR carries a Zacks Rank #5 (Strong Sell). We suggest investors to sell the stock at present.</p>
<p><a href="https://www.zacks.com/stock/news/2340069/amkor-falls-18-in-3-months-how-should-investors-play-the-stock?cid=CS-BENZ-FT-analyst_blog|rank_focused-2340069">To read this article on Zacks.com click here.</a></p>


Large Cap

Mid Cap

Tech

AMKR

Amkor Falls 18% in 3 Months: How Should Investors Play the Stock?

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p><strong>Super Micro Computer</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/smci-stock-quote/"><strong>SMCI</strong></a>) stock is a hot topic among traders on Monday as the company <a href="https://qz.com/super-micro-computer-stock-sp-500-ai-1851343791">joins the <strong>S&amp;P 500</strong></a> today.</p>



<p>This comes as shares of SMCI stock have seen incredible gains over the last year due to the artificial intelligence (<span>AI</span>) boom. That has Super Micro Computer stock up more than 1,000% over the prior 12 months.</p>



<p>With that increasing value comes more recognition, which has earned the company its spot on the S&amp;P. A key point of interest for investors is the company&rsquo;s computer servers and infrastructure.</p>



<p>With the increasing demand for AI comes more need for servers. That&rsquo;s something that Super Micro Computer can offer to customers, both in the government and in the private sector.</p>



<h2>SMCI Stock Tied to NVDA Shares</h2>



<p>Adding to this is the connection between Super Micro Computer and <strong>Nvidia</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/nvda-stock-quote/"><strong>NVDA</strong></a>). Super Micro Computer uses Nvidia graphics processing units (GPUs) in its servers. These are what power AI.</p>



<p>In addition to Super Micro Computer joining the S&amp;P 500, it could also be up alongside NVDA stock today. The GPU maker is set to <a href="https://investorplace.com/2024/03/nvda-stock-alert-7-things-to-know-before-nvidia-gtc-2024/">start its annual GPU Technology Conference (GTC)</a> later today. This could bring additional boons to SMCI stock.</p>



<p>SMCI stock is up 3.4% as of Monday morning.</p>



<p>Investors will find more of the latest stock market stories below!</p>



<p>We have all of the hottest stock market news worth reading about on Monday! A few examples include what&rsquo;s going on with shares of <strong>Globus Maritime</strong>&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/glbs-stock-quote/"><strong>GLBS</strong></a>), <strong>VirnetX Holding</strong>&nbsp;(NYSE:<a href="https://investorplace.com/stock-quotes/vhc-stock-quote/"><strong>VHC</strong></a>) and <strong>Zivo Bioscience</strong>&nbsp;(OTCMKTS:<a href="https://investorplace.com/stock-quotes/zivo-stock-quote/"><strong>ZIVO</strong></a>) stock today. All of that is ready to go at the links below!</p>



<h2>More Monday Stock Market News</h2>



<ul><li><a href="https://investorplace.com/earning-results/2024/03/glbs-stock-earnings-globus-maritime-for-q4-of-2023/">GLBS Stock Earnings: Globus Maritime Beats EPS, Beats Revenue for Q4 2023</a></li>



<li><a href="https://investorplace.com/earning-results/2024/03/vhc-stock-earnings-virnetx-holding-for-q4-of-2023/">VHC Stock Earnings: VirnetX Holding Reported Results for Q4 2023</a></li>



<li><a href="https://investorplace.com/earning-results/2024/03/zivo-stock-earnings-zivo-bioscience-for-q4-of-2023/">ZIVO Stock Earnings: Zivo Bioscience Reported Results for Q4 2023</a></li>
</ul><p><em>On the date of publication, William White&nbsp;did not hold (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;</em><a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank"><em>Publishing Guidelines</em></a><em>.</em></p>
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	<p>The post <a href="https://investorplace.com/2024/03/smci-stock-alert-super-micro-computer-joins-the-sp-500-today/">SMCI Stock Alert: Super Micro Computer Joins the S&amp;P 500 Today</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

SMCI Stock Alert: Super Micro Computer Joins the S&P 500 Today

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p><strong>Zivo Bioscience</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/zivo-stock-quote/"><strong>ZIVO</strong></a></span>) just reported results for the fourth quarter of 2023.</p><ul><li>Zivo Bioscience reported earnings per share of -96 cents.</li><li>The company reported revenue of $11,800.</li></ul><div><p>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT793992">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/02/wall-street-legend-issues-urgent-ai-code-red/?cid=MKT781156&amp;eid=MKT793990">&ldquo;America&rsquo;s Top Trader&rdquo; Issues A.I. Code Red: Act Now or Miss Out</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793999">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	<p>The post <a href="https://investorplace.com/earning-results/2024/03/zivo-stock-earnings-zivo-bioscience-for-q4-of-2023/">ZIVO Stock Earnings: Zivo Bioscience Reported Results for Q4 2023</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

ZIVO Stock Earnings: Zivo Bioscience Reported Results for Q4 2023

Maxim Group analyst Anthony Vendetti maintained a Buy rating on Zivo Bioscience (ZIVO – Research Report) yesterday. The company's shares closed las...

Zivo Bioscience (ZIVO) Gets a Buy from Maxim Group

Warning: ZIVO is at high risk of performing badly

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p><strong>Zivo Bioscience</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/zivo-stock-quote/"><strong>ZIVO</strong></a></span>) just reported results for the first quarter of 2024.</p><ul><li>Zivo Bioscience reported earnings per share of -47 cents.</li><li>The company reported revenue of $35,720.</li></ul><div><p>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	<p>The post <a href="https://investorplace.com/earning-results/2024/05/zivo-stock-earnings-zivo-bioscience-for-q1-of-2024/">ZIVO Stock Earnings: Zivo Bioscience Reported Results for Q1 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

ZIVO Stock Earnings: Zivo Bioscience Reported Results for Q1 2024

Zivo Bioscience (ZIVO) just unveiled an announcement. Zivo Bioscience, Inc. has implemented new incentive plans to motivate non-employee directors ...

Zivo Bioscience Enhances Equity Incentive Plans for Leadership

Zivo Bioscience (ZIVO) has provided an announcement. ZIVO Bioscience Inc. has expanded its Board of Directors and welcomed Laith Yaldoo as the new ...

Zivo Bioscience Strengthens Board with New Director Appointment

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p><strong>Zivo Bioscience</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/zivo-stock-quote/"><strong>ZIVO</strong></a></span>) just reported results for the second quarter of 2024.</p><ul><li>Zivo Bioscience reported earnings per share of -$2.78.</li><li>The company did not report any revenue for the quarter.</li></ul><div><p>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><p>The post <a href="https://investorplace.com/earning-results/2024/08/zivo-stock-earnings-zivo-bioscience-for-q2-of-2024/">ZIVO Stock Earnings: Zivo Bioscience Reported Results for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

ZIVO Stock Earnings: Zivo Bioscience Reported Results for Q2 2024

GLBS

NVDA

SMCI

Press Releases

ZIVO Bioscience to Present at the Dawson James Small Cap Growth Conference

ZIVO Bioscience Announces Reverse Stock Split

ZIVO Bioscience Initiates 42-Day Validation Study with Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler Chickens

ZIVO Bioscience Reports Positive Efficacy Results from 42-Day Validation Study with Non-Antibiotic Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler Chickens

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

Zivo Bioscience

Zivo Bioscience (ZIVO) Forecast

Zivo Bioscience (OTC:ZIVO) Stock, Quote.Headers.trade-ideas